Document 0842 DOCN M9480842 TI Evaluation of a direct ELISA HIV-1/HIV-2 EIA using synthetic peptides: detect-HIV (version 2). DT 9410 AU Chalifour RJ; Ha NH; Barbeau S; Lacroix M; BioChem ImmunoSystems Inc., Montreal, Que., Canada. SO Abstr Gen Meet Am Soc Microbiol. 1994;94:554 (abstract no. C-362). Unique Identifier : AIDSLINE ASM94/94313103 AB A direct ELISA version of BioChem ImmunoSystems' synthetic peptide EIA was evaluated to establish if detecting all immunoglobulin classes improves the sensitivity of this test. HRP conjugates of 3 peptides from HIV-1 GP120, HIV-1 GP41 and HIV-2 GP36 were used to detect antibodies captured by these peptides on microtiter plates. Pending confirmatory testing, the specificity of this EIA was 99.5% (1974 fresh samples tested) while the sensitivity was 100% for HIV-1 (50/50) and 100% for HIV-2 (15/15). By testing serially diluted samples the sensitivity of the direct EIA was found to surpass that of the indirect EIA (version 1) with seroconversion samples and was of similar sensitivity with samples from later stages of HIV infection. The signal of both the direct and indirect EIAs was reduced by > 90% after IgG absorption by Protein G except with seroconversion samples where only a 30% signal reduction occurred with the direct EIA. This indicated that the improved sensitivity of the direct EIA with samples taken during seroconversion is because the direct EIA format detects IgG as well as other immunoglobulin classes. DE Enzyme-Linked Immunosorbent Assay/*METHODS Human HIV Antibodies/BLOOD HIV Envelope Protein gp120/*ANALYSIS HIV Envelope Protein gp41/*ANALYSIS HIV Seropositivity/*DIAGNOSIS HIV-1/*ISOLATION & PURIF HIV-2/*ISOLATION & PURIF IgG/BLOOD Peptides/CHEMICAL SYNTHESIS Sensitivity and Specificity Viral Envelope Proteins/*ANALYSIS MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).